Menu

Department of Pharmaceuticals Tender by National Institute Of Pharmaceutical Education And Research (niper)mohali (GEM/2025/B/6102438)

CDCL3 ZERO POINT ZERO THREE V BYE V PERCENT TMS NINTY NINE POINT EIGHT PERCENT, 100 ML,DMSO ZERO PO

Goods
Qty:58
Department of Pharmaceuticals Tender by National Institute Of Pharmaceutical Education And
Research (niper)mohali (GEM/2025/B/6102438)

Tender Timeline

Tender Issue
April 1, 2025 at 2:27 PM
Corrigendum
April 23, 2025 at 10:28 AM
Bid Extended to April 30, 2025 at 10:00 AM

Tender Title:

GEM/2025/B/6102438

Issuing Authority:

Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers


Scope of Work and Objectives:

This tender aims to procure a specialized chemical solution categorized as CDCL3 ZERO POINT ZERO THREE V BYE V PERCENT TMS NINTY NINE POINT EIGHT PERCENT in various volumes (100 ML, 50 ML) along with other similar chemical compounds as detailed in the tender specifications. The primary objective is to secure high-quality chemical solutions for pharmaceutical applications, ensuring compliance with industry standards and requirements.

Eligibility Criteria:

To qualify for this tender, bidders must meet the following eligibility requirements:

  • Be a registered entity in compliance with government procurement policies.
  • Have experience in supplying pharmaceutical-grade chemicals.
  • Provide evidence of previous successful deliveries of similar items.

Technical Requirements:

The technical specifications demand that all chemical solutions must meet stringent quality standards, including:

  • Purity levels as per the defined specifications.
  • Safety and compliance with environmental regulations.
  • Must include material safety data sheets (MSDS) for all products.

Financial Requirements:

Vendors are required to submit a Financial Bid that details:

  • Pricing for each item listed in the bid.
  • Terms of payment and any applicable taxes.
  • An Earnest Money Deposit (EMD), the specifics of which are detailed in the tender documentation.

Document Submission Details:

All interested parties must submit their bids electronically through the specified online procurement portal. Required documents include:

  • Technical proposal.
  • Financial proposal.
  • Certificates of compliance with quality standards.
  • Any relevant registration certificates.

Special Provisions:

This tender includes specific provisions for Micro and Small Enterprises (MSEs) to encourage participation from startups and smaller businesses. Bidders claiming MSE status must provide appropriate documentation to confirm eligibility for benefits under the policy.

Evaluation Process:

Bids will be evaluated based on the following criteria:

  • Compliance with technical specifications.
  • Pricing and overall cost-effectiveness.
  • Delivery timelines proposed by the bidders.

Delivery Locations:

The successful bidders will be required to deliver the products to various designated locations as specified in the subsequent communications post-award.

Contact Information:

For further inquiries and clarifications, potential bidders are encouraged to reach out electronically to the designated contacts listed in the official tender documents.

Additional Information:

Bidders must ensure that they are proactively engaged throughout the procurement process to stay updated with any modifications or clarifications issued by the Department of Pharmaceuticals.


General Information

Item Category
CDCL3 ZERO POINT ZERO THREE V BYE V PERCENT TMS NINTY NINE POINT EIGHT PERCENT, 100 ML , DMSO ZERO POINT ZERO THREE V BYE V PERCENT TMS NINTY NINE POINT EIGHT PERCENT, 50 ML , D2O ZERO POINT ZERO THREE V BYE V PERCENT TMS NINTY NINE POINT NINE PERCENT, 100 ML , MEOD ZERO POINT ZERO THREE V BYE V PERCENT TMS NINTY NINE POINT FIVE PERCENT, 10 ML

Financial Information

Bid Offer Validity
120 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

6 Documents
GeM-Bidding-7698128.pdfMain Document
Other DocumentsOTHER
Other DocumentsOTHER
Other DocumentsOTHER
Other DocumentsOTHER
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Certificate (Requested in ATC)
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Corrigendum Updates

Bid Extended to April 30, 2025 at 10:00 AMModified on April 23, 2025 at 10:28 AM
Bid Opening April 30, 2025 at 10:30 AM

Similar Tenders

View All

Botulinum Toxin 100 units 1ml Inj,Fluoresceine Sodium 20 percent 3ml Inj,Fluconazole 0 point 3perce

GEM
Goods
Qty:8,056
4 Files
Indian Army
AMBALA, HARYANA
Boq › Boql
Botulinum Toxin 100 units 1ml Inj , Fluoresceine Sodium 20 percent 3ml Inj , Fluconazole 0 point 3percent w v bott of 5ml Eye drop , Moxifloxacin 0point5percent Preservative Free Eye Drops , Homatropine Hydrochloride 2 percent Eye drops , Ketotifen Fumarate 0 point 05 percent Eye drops 5ml , Ketorolac Tromethamine 0point4percent Eye drops 5ml , Brimonidine Tartrate 0point2percent Eye drops 5ml , Lotepredenol etabonate 0point5percent bott of 5ml , Methyl Cellullose 2percent solution bottle , Natamycin 3percent eye drops in 3 ml bott , Pilocarpine Nitrate eye solution 2 percent bott of 5 ml , Pilocarpine Intracameral Inj 0point5percent Pilocarpine , Povidone 5percent eye drop bott of 5 ml , Sodium Chromoglycate eye drops 2percent bott of 5 ml , Sodium Chloride 6 percent w w ointment Tube of 3 gm , Sodium Chloride eye drops 5 percent 5 ml , Tropicamide 1 percent with 5 percent Phenylephrine eye , Tropicamide Eye solution 1 percent bott of 5 ml , Bimatoprost 0 point 03 percent bott of 3ml , E D Timolol Maleate 0 point 5 percent Preservative free , Brimonidine Tartarate 0 point 2 percent plus Timolol , Flurometholone 0point1percent w v Eye drop 5 ml , Latanoprost 0point005percent w v Eye drop 5 ml , Nepafenac 0point1percent w v with carbomer 970 , Moxifloxacin 0point5percent with Dexamethasone , Olopatadine 0point2percent w v Eye drop 5 ml , Olopatadine 0 point1 percent with Ketorolac , Moxifloxacin 0point5percent Ung 5 gm , Proparacaine 0point5percent Eye drops 5 ml , Eye Drop Moxifloxacin Hydrochloride
April 8, 2025
April 29, 2025 at 1:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity, having adequate experience in supplying pharmaceutical-grade solutions, and providing documentation to verify compliance with industry standards. Bidders should also demonstrate a robust track record of fulfilling similar orders to enhance credibility during the evaluation phase. Ensuring the required documentation is complete and submitted on time is essential for eligibility.

The technical specifications demand that all submitted chemical solutions meet strict quality standards, such as their purity level and compliance with all safety regulations. Bidders should provide comprehensive data, including Material Safety Data Sheets (MSDS), to prove adherence to these standards. Furthermore, each solution must contribute to ensuring safety in pharmaceutical applications, reflecting the tender’s commitment to quality.

The Earnest Money Deposit (EMD) is a specified amount that bidders must submit along with their financial proposals to ensure serious participation. The exact amount and payment instructions can be found in the tender documentation. It’s crucial for bidders to include this to avoid disqualification and demonstrate their commitment to the bidding process.

Proposals must be submitted electronically through the designated government procurement portal. Bidders should ensure that they adhere to the guidelines outlined in the tender document regarding submission methods, ensuring all required documents are attached. Maintaining clarity and organization in the submission will be beneficial for the evaluation process.

MSEs can avail special provisions that may include relaxations in eligibility criteria, access to procurement tender opportunities, and possible price preference during the evaluation process. This encourages greater participation from smaller firms, aligning with the government’s commitment to foster growth in the MSE sector and adhere to Make in India policies. Ensure you submit all necessary certification to claim these benefits.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders